Advertisement
Screener

WADE G W & INC Historic Quarter Change: Foreign Stocks, Added

WADE G W & INC historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2023-12-31, WADE G W & INC opened 7 positions, added to 11, reduced 6 and sold out of 5.

  • Q1 2016: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 79,406.
  • Q4 2015: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 77,658.
  • Q4 2015: Stock PVCT; Country of operation United States; Class COM; Shares before 30,000.
  • Q3 2015: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 68,258.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1132556), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-01); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-05); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-26); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-15); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-04); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-11); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2000-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2016ULXXXX
UNILEVER PLC
SPON ADR NEW79,40688,822+9,416$3,424,000$4,013,000+$589,0002016-04-26
Q4 2015ULXXXX
UNILEVER PLC
SPON ADR NEW77,65879,406+1,748$3,167,000$3,424,000+$257,0002016-01-12
Q4 2015PVCT
PROVECTUS BIOPHARMACEUTICALS
United StatesCOM30,00080,000+50,000$17,000$31,000+$14,0002016-01-12
Q3 2015ULXXXX
UNILEVER PLC
SPON ADR NEW68,25877,658+9,400$2,932,000$3,167,000+$235,0002015-10-15
Q2 2015ULXXXX
UNILEVER PLC
SPON ADR NEW66,80768,258+1,451$2,787,000$2,932,000+$145,0002015-08-14
Q3 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR73,646105,521+31,875$3,861,000,000$5,672,000-$3,855,328,0002014-11-13
Q2 2014TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR56,64073,646+17,006$2,993,000$3,861,000,000+$3,858,007,0002014-08-14
Q2 2014ULXXXX
UNILEVER PLC
SPON ADR NEW83,62484,946+1,322$3,577,000$3,849,000,000+$3,845,423,0002014-08-14
Q1 2014ULXXXX
UNILEVER PLC
SPON ADR NEW82,62183,624+1,003$3,404,000$3,577,000+$173,0002014-05-14
Q4 2013ULXXXX
UNILEVER PLC
SPON ADR NEW80,65282,621+1,969$3,112,000,000$3,404,000-$3,108,596,0002014-02-11
Q3 2013ULXXXX
UNILEVER PLC
SPON ADR NEW80,32980,652+323$3,249,000$3,112,000,000+$3,108,751,0002013-11-13

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet